"Tazalok" - a drug that has a complex effect on the woman's body. In this case, its composition is selected in such a way that each component of the drug enhances the effect of others, i.e. A synergistic effect is observed.
Flavonoids of biologically active substances in the composition of a plant preparation are similar in their structure to a hormone estrogen, but do not exhibit a characteristic effect. By replacing estrogens, flavonoids inhibit the conversion of androgens to estrogens if there is a surplus. Thus, the ratio of sex hormones in women is optimized.
Due to the ability of the drug to control the production of gonadotropic hormones that regulate the sexual glands, "Tazalok" is able to quickly and effectively normalize the menstrual cycle in women, stabilizing its second phase. A sedative and restorative effect of the drug helps actively combat the painful manifestations of premenstrual syndrome and menopause.
The drug has a sufficient analgesic and antispasmodic effect. Its reception helps to remove painful and simply unpleasant sensations accompanying menstrual bleeding.
Positive effect of components of "Tazalok" on the tissues of internal genital organs and mammary glands, in particular uterus and ovaries, was noted. The use of the drug prevents the development of processes caused by dysplasia, or otherwise disorders in the formation of tissues of female organs.
Due to anti-inflammatory, antitumor and antiproliferative action, "Tazalok" prevents the growth of tumors, not allowing cells of neoplasms to spread. It effectively prevents too much growth of tissues, which makes the drug useful in endometriosis. With polycystic ovaries, "Tazalok" helps soften the cystic capsule and relieve tension in it. In this case, the drug helps to perform its functions normally to a healthy ovary or part of it.